Skip to main content
OpenTrials

Clinical trial condition

Myelofibrosis

Explore clinical trials studying Myelofibrosis. Study availability and eligibility vary by location and protocol.

175 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Myelofibrosis trial results

Recruiting

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

NCT05488548

Conditions
Bone Marrow Diseases, Castrate Resistant Prostate Cancer, Chronic Disease, +16 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
View Trial Details
Recruiting

Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera

NCT06516406

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Azienda Ospedaliera Annunziata Cosenza, Calabria, Italy
  • Grande Ospedale Metropolitano "Bianchi Melacrino Morelli" Reggio Calabria, Calabria, Italy
  • Università degli Studi di Napoli Federico II U.O.C. di Ematologia e Trapianti di midollo Naples, Campania, Italy
  • IRCCS Policlinico Sant'Orsola Bologna, Emilia-Romagna, Italy
View all 26 locations
View Trial Details
Recruiting

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

NCT05280509

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Gabrail Cancer Center Canton, Ohio, United States
  • University of Cincinnati (UC) Cincinnati, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 19 locations
View Trial Details

Related conditions